Cecilia M. Giachelli

Cecilia M. Giachelli's AcademicInfluence.com Rankings

Engineering

#4553

World Rank

#5753

Historical Rank

Biomedical Engineering

#291

World Rank

#298

Historical Rank

engineering Degrees

Download Badge

Engineering

Cecilia M. Giachelli's Degrees

PhD Biomedical Engineering University of Washington

Why Is Cecilia M. Giachelli Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Cecilia M. Giachelli's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Phosphate regulation of vascular smooth muscle cell calcification. (2000) (1362)
Smooth Muscle Cell Phenotypic Transition Associated With Calcification: Upregulation of Cbfa1 and Downregulation of Smooth Muscle Lineage Markers (2001) (805)
Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate (2011) (747)
Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. (1993) (687)
Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascular Disease (2007) (590)
The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. (1995) (562)
Vascular calcification mechanisms. (2004) (547)
Osteopontin: a versatile regulator of inflammation and biomineralization. (2000) (545)
Smooth Muscle Cells Give Rise to Osteochondrogenic Precursors and Chondrocytes in Calcifying Arteries (2009) (522)
Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness (2018) (498)
Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. (1999) (465)
NF-κB Mediates αvβ3 Integrin-induced Endothelial Cell Survival (1998) (456)
Osteopontin is expressed in human aortic valvular lesions. (1995) (456)
The emerging role of phosphate in vascular calcification. (2009) (442)
Role of the Sodium-Dependent Phosphate Cotransporter, Pit-1, in Vascular Smooth Muscle Cell Calcification (2006) (433)
Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. (1994) (420)
Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. (2002) (411)
The role of osteopontin in inflammatory processes (2009) (407)
Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. (1998) (399)
Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. (1995) (380)
Role of osteopontin in cellular signaling and toxicant injury. (2001) (345)
Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. (2004) (334)
Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells* (2000) (331)
Phosphorylation of Osteopontin Is Required for Inhibition of Vascular Smooth Muscle Cell Calcification* (2000) (328)
Fibroblast growth factor 23 is not associated with and does not induce arterial calcification (2013) (323)
Vascular calcification in chronic kidney disease. (2004) (323)
Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. (1994) (321)
Inactivation of the Osteopontin Gene Enhances Vascular Calcification of Matrix Gla Protein–deficient Mice (2002) (313)
Osteoprotegerin Inactivation Accelerates Advanced Atherosclerotic Lesion Progression and Calcification in Older ApoE−/− Mice (2006) (309)
Regulation of Vascular Calcification: Roles of Phosphate and Osteopontin (2005) (306)
Vascular calcification: in vitro evidence for the role of inorganic phosphate. (2003) (292)
Macrophages express osteopontin during repair of myocardial necrosis. (1994) (292)
Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. (1999) (290)
Vascular Calcification: An Update on Mechanisms and Challenges in Treatment (2013) (289)
Vascular calcification and inorganic phosphate. (2001) (279)
Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. (1992) (276)
Free Fatty Acid Impairment of Nitric Oxide Production in Endothelial Cells Is Mediated by IKKβ (2005) (272)
BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. (2008) (266)
Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. (2003) (255)
A current understanding of vascular calcification in CKD. (2014) (249)
Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease. (2013) (247)
Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. (1994) (245)
Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction. (1996) (242)
Osteopontin N-terminal Domain Contains a Cryptic Adhesive Sequence Recognized by α9β1 Integrin* (1996) (240)
Inhibition of bone morphogenetic protein protects against atherosclerosis and vascular calcification (2010) (234)
Engineering biomaterials to integrate and heal: The biocompatibility paradigm shifts (2012) (233)
Ectopic calcification: gathering hard facts about soft tissue mineralization. (1999) (233)
Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet (2012) (232)
Regulation of cardiovascular calcification. (2004) (218)
Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin. (2009) (217)
αvβ3 Integrin Expression in Normal and Atherosclerotic Artery (1995) (212)
Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho. (2017) (206)
The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation. (2004) (204)
Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells. (2000) (200)
Osteopontin Expression in Cardiovascular Diseases a (1995) (197)
Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. (1995) (188)
Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). (1991) (187)
Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-κB loop (1999) (185)
Osteopontin and beta 3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp-dependent endothelial migration in vitro. (1995) (181)
Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin). (1994) (177)
Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta. (2005) (168)
A fibrinogen-based precision microporous scaffold for tissue engineering. (2007) (165)
Calcification of Advanced Atherosclerotic Lesions in the Innominate Arteries of ApoE-Deficient Mice: Potential Role of Chondrocyte-Like Cells (2005) (163)
Microporous nanofibrous fibrin-based scaffolds for bone tissue engineering. (2008) (158)
Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease. (2011) (158)
Smooth muscle cell plasticity: fact or fiction? (2013) (157)
The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival. (2004) (154)
Myocardial osteopontin expression is associated with left ventricular hypertrophy. (1997) (144)
Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis (2010) (136)
Characterization of cloned aortic smooth muscle cells from young rats. (1994) (134)
Molecular and cellular biology of osteopontin Potential role in cardiovascular disease. (1995) (124)
Sources of cells that contribute to atherosclerotic intimal calcification: an in vivo genetic fate mapping study. (2012) (119)
Inducers and inhibitors of biomineralization: lessons from pathological calcification. (2005) (118)
Sodium-Dependent Phosphate Cotransporters and Phosphate-Induced Calcification of Vascular Smooth Muscle Cells: Redundant Roles for PiT-1 and PiT-2 (2013) (118)
Osteopontin expression in fetal and mature human kidney. (1999) (117)
Development of an esophagus acellular matrix tissue scaffold. (2006) (114)
Immobilization of alkaline phosphatase on microporous nanofibrous fibrin scaffolds for bone tissue engineering. (2009) (114)
Direct effects of phosphate on vascular cell function. (2011) (113)
Chimeric Peptides of Statherin and Osteopontin That Bind Hydroxyapatite and Mediate Cell Adhesion* (2000) (112)
Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation. (1997) (112)
Esophageal epithelial cell interaction with synthetic and natural scaffolds for tissue engineering. (2005) (111)
Phosphate and vascular calcification: Emerging role of the sodium-dependent phosphate co-transporter PiT-1 (2010) (110)
Smooth muscle cell matrix metalloproteinase production is stimulated via alpha(v)beta(3) integrin. (2000) (110)
Smooth muscle cells deficient in osteopontin have enhanced susceptibility to calcification in vitro. (2005) (105)
Runx2 Expression in Smooth Muscle Cells Is Required for Arterial Medial Calcification in Mice. (2015) (105)
A subpopulation of smooth muscle cells in injured rat arteries expresses platelet-derived growth factor-B chain mRNA. (1995) (105)
Structural Requirements for α9β1-Mediated Adhesion and Migration to Thrombin-Cleaved Osteopontin (1998) (104)
Mimicking cell-cell interactions at the biomaterial-cell interface for control of stem cell differentiation. (2006) (102)
Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by alpha9beta1 integrin. (1996) (100)
Delivery of non-viral gene carriers from sphere-templated fibrin scaffolds for sustained transgene expression. (2007) (100)
Mechanisms of vascular calcification. (2007) (93)
A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat. (1998) (92)
RANKL Enhances Macrophage Paracrine Pro-Calcific Activity in High Phosphate-Treated Smooth Muscle Cells: Dependence on IL-6 and TNF-α (2012) (87)
Alpha-v beta-3 integrin expression in normal and atherosclerotic artery. (1995) (86)
Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-kappa B loop. (1999) (83)
Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function (2008) (80)
Phosphate uptake-independent signaling functions of the type III sodium-dependent phosphate transporter, PiT-1, in vascular smooth muscle cells. (2015) (79)
Controlling osteopontin orientation on surfaces to modulate endothelial cell adhesion. (2005) (78)
Osteopontin mediates macrophage chemotaxis via α4 and α9 integrins and survival via the α4 integrin (2013) (76)
NF-k B Mediates a v b 3 Integrin-induced Endothelial Cell Survival (1998) (74)
Adhesive protein interactions with chitosan: consequences for valve endothelial cell growth on tissue-engineering materials. (2003) (74)
Biomimetic peptides that engage specific integrin-dependent signaling pathways and bind to calcium phosphate surfaces. (2003) (74)
Matrix remodeling in vascular calcification associated with chronic kidney disease. (2010) (74)
Runx2 deletion in smooth muscle cells inhibits vascular osteochondrogenesis and calcification but not atherosclerotic lesion formation. (2016) (72)
The alpha(v)beta3 integrin, NF-kappaB, osteoprotegerin endothelial cell survival pathway. Potential role in angiogenesis. (2002) (72)
The role of osteopontin in foreign body giant cell formation. (2005) (72)
Decorin Promotes Aortic Smooth Muscle Cell Calcification and Colocalizes to Calcified Regions in Human Atherosclerotic Lesions (2004) (71)
Ectopic calcification: new concepts in cellular regulation (2001) (68)
Tubulointerstitial injury and loss of nitric oxide synthases parallel the development of hypertension in the Dahl‐SS Rat (2000) (68)
Osteopontin protects against high phosphate-induced nephrocalcinosis and vascular calcification. (2016) (68)
Prevascularized microtemplated fibrin scaffolds for cardiac tissue engineering applications. (2013) (68)
Surface-bound orientated Jagged-1 enhances osteogenic differentiation of human periodontal ligament-derived mesenchymal stem cells. (2013) (68)
Differential expression of alpha 1 type VIII collagen in injured platelet-derived growth factor-BB--stimulated rat carotid arteries. (1996) (67)
Osteopontin regulation in cultured rat renal epithelial cells. (1997) (65)
Restricted expression of homeobox genes distinguishes fetal from adult human smooth muscle cells. (1996) (63)
Osteopontin expression in human crescentic glomerulonephritis. (2000) (63)
Angiotensin II induction of osteopontin expression and DNA replication in rat arteries. (1996) (61)
Developmentally regulated cytochrome P-450IA1 expression in cultured rat vascular smooth muscle cells. (1991) (60)
Src Kinase Activity Is Required for Integrin αVβ3-Mediated Activation of Nuclear Factor-κB* (2005) (59)
Immunohistologic labeling of murine endothelium. (2003) (59)
Hyaluronic acid grafting mitigates calcification of glutaraldehyde-fixed bovine pericardium. (2004) (59)
Crosslinking of an oesophagus acellular matrix tissue scaffold (2008) (59)
Developmental regulation of cytochrome P-450 genes in the rat. (1987) (58)
SLC20A2 Deficiency in Mice Leads to Elevated Phosphate Levels in Cerbrospinal Fluid and Glymphatic Pathway‐Associated Arteriolar Calcification, and Recapitulates Human Idiopathic Basal Ganglia Calcification (2017) (58)
High phosphate feeding promotes mineral and bone abnormalities in mice with chronic kidney disease. (2013) (57)
Sodium-dependent phosphate cotransporters and vascular calcification (2007) (57)
Upregulation of osteopontin expression in renal cortex of streptozotocin-induced diabetic rats is mediated by bradykinin. (1998) (57)
Characterization of an in vitro model for evaluating the interface between skin and percutaneous biomaterials (2006) (57)
Novel insights into vascular calcification. (2006) (56)
Linoleic acid-stimulated vascular adhesion molecule-1 expression in endothelial cells depends on nuclear factor-kappaB activation. (2002) (56)
Interaction of vascular and bone disease in patients with normal renal function and patients undergoing dialysis (2007) (56)
Effects of 3-methylcholanthrene and phenobarbital on the capacity of embryos to bioactivate teratogens during organogenesis. (1985) (49)
Generation of mouse conditional and null alleles of the type III sodium‐dependent phosphate cotransporter PiT‐1 (2009) (49)
Discoidin domain receptor-1 deficiency attenuates atherosclerotic calcification and smooth muscle cell-mediated mineralization. (2009) (48)
Metanephric osteopontin regulates nephrogenesis in vitro. (1997) (47)
The pathogenesis of tubulointerstitial disease associated with glomerulonephritis: the glomerular cytokine theory. (1995) (46)
Activation of IKKbeta by glucose is necessary and sufficient to impair insulin signaling and nitric oxide production in endothelial cells. (2005) (44)
Mechanisms of vascular calcification in uremia. (2004) (44)
Autocrine secretion of osteopontin by vascular smooth muscle cells regulates their adhesion to collagen gels. (1996) (43)
Methods to promote Notch signaling at the biomaterial interface and evaluation in a rafted organ culture model. (2009) (42)
Characterization and analysis of osteopontin-immobilized poly(2-hydroxyethyl methacrylate) surfaces. (2003) (41)
Enhancing the biological activity of immobilized osteopontin using a type-1 collagen affinity coating. (2004) (41)
Upstream stimulatory factor 1 regulates osteopontin expression in smooth muscle cells. (1999) (40)
Mitigation of Ectopic Calcification in Osteopontin-Deficient Mice by Exogenous Osteopontin (2005) (40)
Structural requirements for alpha 9 beta 1-mediated adhesion and migration to thrombin-cleaved osteopontin. (1998) (40)
Vitamin D Receptor Activators Induce an Anticalcific Paracrine Program in Macrophages: Requirement of Osteopontin (2010) (39)
Src kinase activity is required for integrin alphaVbeta3-mediated activation of nuclear factor-kappaB. (2005) (39)
Effects of cyclosporine in osteopontin null mice1 (2002) (38)
PiT-2, a type III sodium-dependent phosphate transporter, protects against vascular calcification in mice with chronic kidney disease fed a high-phosphate diet. (2018) (38)
CD44 is not an adhesive receptor for osteopontin (1999) (37)
Arteriosclerosis, calcium phosphate deposition and cardiovascular disease in uremia: current concepts at the bench (2005) (36)
Role of β1 and β3 Integrins in Human Smooth Muscle Cell Adhesion to and Contraction of Fibrin Clots In Vitro (1998) (36)
Formation of the arterial media during vascular development. (1995) (35)
Osteopontin expression in human cyclosporine toxicity. (2001) (34)
Engineered Biomaterials Control Differentiation and Proliferation of Human-Embryonic-Stem-Cell-Derived Cardiomyocytes via Timed Notch Activation (2014) (32)
Characterization of mandibular bone in a mouse model of chronic kidney disease. (2010) (30)
Osteopontin expression, tubulointerstitial disease, and essential hypertension. (1998) (28)
Molecular Mediators of αvβ3-Induced Endothelial Cell Survival (2006) (28)
Regulation of cytochrome P-450b and P-450e mRNA expression in the developing rat. Hybridization to synthetic oligodeoxyribonucleotide probes. (1986) (27)
Platelet-derived growth factor-A mRNA expression in fetal, normal adult, and atherosclerotic human aortas. Analysis by competitive polymerase chain reaction. (1996) (26)
Slc20a2 deficiency results in fetal growth restriction and placental calcification associated with thickened basement membranes and novel CD13 and lamininα1 expressing cells. (2016) (26)
Effects of cyclosporine in osteopontin null mice. (2002) (24)
Expression of osteopontin in the head process late in gastrulation in the rat. (1995) (24)
Mice lacking the sodium-dependent phosphate import protein, PiT1 (SLC20A1), have a severe defect in terminal erythroid differentiation and early B cell development. (2013) (24)
Expression and function of the integrin alpha9beta1 in bovine aortic valve interstitial cells. (2003) (22)
Engineering macrophages to control the inflammatory response and angiogenesis. (2015) (22)
In Vivo Stimulation of Vascular Plasminogen Activator Inhibitor-1 Production by very Low-Density Lipoprotein Involves Transcription Factor Binding to a VLDL-Responsive Element (2000) (22)
Relevance of Smooth Muscle Replication and Development to Vascular Disease (1995) (21)
Macrophages: The Bad, the Ugly, and the Good in the Inflammatory Response to Biomaterials (2017) (20)
Role of carbonic anhydrase II in ectopic calcification. (2009) (20)
Carbon monoxide inhibits monooxygenation by the conceptus and embryotoxic effects of proteratogens in vitro. (1986) (20)
Anti-calcification of bovine pericardium for bioprosthetic heart valves after surface modification with hyaluronic acid derivatives (2005) (19)
Increased Calcific Aortic Valve Disease in response to a diabetogenic, procalcific diet in the LDLr-/-ApoB100/100 mouse model. (2018) (18)
Role of beta1 and beta3 integrins in human smooth muscle cell adhesion to and contraction of fibrin clots in vitro. (1998) (18)
Isolation and characterization of rat cytochrome P-450IIB gene family members. Use of the polymerase chain reaction to detect expression of a novel P-450 mRNA. (1989) (17)
Characterization of human aortic smooth muscle cells expressing HPV16 E6 and E7 open reading frames. (1995) (16)
Loss of PiT-2 results in abnormal bone development and decreased bone mineral density and length in mice. (2018) (16)
The influence of surface mineral and osteopontin on the formation and function of murine bone marrow-derived osteoclasts (2008) (13)
Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening following endothelial denudation (1996) (13)
Quantitative interrogation of micropatterned biomolecules by surface force microscopy. (2000) (13)
Loss of PiT-1 results in abnormal endocytosis in the yolk sac visceral endoderm (2014) (11)
An Inducible, Ligand-Independent Receptor Activator of NF-κB Gene to Control Osteoclast Differentiation from Monocytic Precursors (2013) (10)
Synthesis and Collagen Gel Contraction (1996) (7)
Osteopontin: Potential roles in vascular function and dystrophic calcification (2006) (7)
Vascular Calcification: An Update on Mechanisms and Challenges in Treatment (2013) (7)
Combination of Sleeping Beauty transposition and chemically induced dimerization selection for robust production of engineered cells (2012) (7)
Smooth Muscle Cell Matrix Metalloproteinase Production Is Stimulated via a v b 3 Integrin (2000) (7)
Osteoclast precursors do not express CD68: results from CD68 promoter‐driven RANK transgenic mice (2017) (6)
Slc20a1/Pit1 and Slc20a2/Pit2 are essential for normal skeletal myofiber function and survival (2020) (6)
Role of Runx2 in Calcific Aortic Valve Disease in Mouse Models (2021) (6)
Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, FGF-23 and osteopontin (2009) (4)
THE ROLE OF OSTEOPROTEGERIN AND TNF-RELATED APOPTOSIS INDUCING LIGAND IN HUMAN MICROVASCULAR ENDOTHELIAL CELL SURVIVAL (2004) (3)
Engineered Osteoclasts Resorb Necrotic Alveolar Bone in Anti-RANKL Antibody-Treated Mice. (2021) (3)
Ectopic Mineralization: New Concepts in Etiology and Regulation (2008) (3)
THE ROLE OF TYPE III SODIUM-DEPENDENT PHOSPHATE COTRANSPORTER PIT-1 IN SMOOTH MUSCLE CELL CALCIFICATION (2004) (3)
Biodegradable amino acid-hydrogel porous scaffold for the tissue engineering of the heart valve (2002) (2)
Notch signaling biomaterials and tissue regeneration (2014) (2)
Noncanonical Wnts at the Cusp of Fibrocalcific Signaling Processes in Human Calcific Aortic Valve Disease. (2017) (2)
Collagen Gels (2007) (2)
αyβ3integrin expression in normal and atherosclerotic artery (1996) (1)
PHENOTYPIC MODULATION OF SMOOTH MUSCLE CELLS IN CALCIFIED ARTERIES: AN ON-AND-OFF EFFECT ASSOCIATED WITH CULTURE ENVIRONMENT (2004) (1)
OSTEOPONTIN MEDIATED INHIBITION AND REGRESSION OF ECTOPIC CALCIFICATION (2004) (1)
OSTEOPONTIN, AN INDUCIBLE INHIBITOR OF VASCULAR CALCIFICATION IN MATRIX GLA PROTEIN-DEFICIENT MICE (2002) (1)
OSTEOPONTIN IN NEPHROLITHIASIS: CELL CULTURE, ANIMAL, AND HUMAN STUDIES (2002) (1)
Pi genes markers of smooth muscle differentiation and proliferation (1992) (1)
Controlled release of osteoprotegerin for the promotion of angiogenesis (2005) (0)
Production and Purification of an Optimized Osteopontin Peptide for Use in Vascular Calcification Treatment Studies (2011) (0)
Characterization of bovine aortic valve interstitial cells (2000) (0)
Adapter Protein RapGEF1 Is Required for ERK1/2 Signaling in Response to Elevated Phosphate in Vascular Smooth Muscle Cells (2021) (0)
OSTEOPROTEGERIN AN AVB3-INDUCED ENDOTHELIAL CELL SURVIVAL MOLECULE (2004) (0)
We-W39:4 Clinical significance and underlying mechanisms regulating vascular calcification (2006) (0)
MULTIPLE ROLES FOR OSTEOPONTIN IN REGULATING VASCULAR CALCIFICATION (2002) (0)
PDGF-B and injury increase expression of type viii collagen in the rat carotid artery (1996) (0)
Osteopontin, elastin and PDGF B genes are transcriptionally regulated in phenotypically distinct rat aortic smooth muscle cells (1996) (0)
Engineered Osteoclasts for the Treatment and Prevention of Heterotopic Ossification (2015) (0)
Expression of cytochrome P-450 and epoxide hydrolase messenger RNA indeveloping rat embryos (1984) (0)
Calcific Aortic Valve Disease: Where Are We Now? (2014) (0)
Ablation of Slc20a1/PitT1 and Slc20a2/PiT2 in mice in the osteogenic lineage causes dentin dysplasia and formation of ectopic enamel islands (2020) (0)
OSTEOPONTIN INHIBITS SMOOTH MUSCLE CELL CALCIFICATION VIA AN AUTOCRINE MECHANISM THAT MAY INVOLVE BOTH RGD-DEPENDENT AND -INDEPENDENT PATHWAYS (2004) (0)
OSTEOPROTEGERIN PROMOTES ENDOTHELIAL CELL SURVIVAL AND ANGIOGENESIS (2004) (0)
The n-terminal domain of osteopontin may. contain at least two distinct cell attachment sites (1997) (0)
Role of the sodium‐dependent phosphate co‐transporter PiT‐1 in mouse development and vascular calcification (2009) (0)
Progress toward engineered biomaterials that heal (2004) (0)
Role of (cid:98) 1 and (cid:98) 3 Integrins in Human Smooth Muscle Cell Adhesion to and Contraction of Fibrin Clots In Vitro (1998) (0)
Mechanical Testing and Optimizing Cell Seeding on Porous Fibrin Scaffolds (2008) (0)
Abstract 15929: Blocking Osteochondrogenic Differentiation of Activated Valve Interstitial Cells Improves Aortic Valve Function in Diabetic Ldlr-/- Mice (2017) (0)
DDR1: a novel regulator of intimal calcification (2008) (0)
MOLECULAR MEDIATORS OF AVB3 INDUCED NF-KB SURVIVAL SIGNALS IN RAECS (2004) (0)
Osteopontin is transcriptionally regulated in phenotypically distinct rat aortic smooth muscle cells (1997) (0)
Proliferative fibrin scaffolding with acetone enhanced mechanical properties (2008) (0)
Control of Endothelial and Smooth Muscle Function by Extracellular Matrix (1997) (0)
Osteoclasts in Cardiovascular Calcification (2020) (0)
Cell-Seeded Fibrin Scaffolds for Cardiac Tissue Engineering (2010) (0)
Arterial calcification in chronic kidney disease (CKD): role of phosphate and phosphate transporters (2013) (0)
Biomaterials that talk (1999) (0)
87: Active Vitamin D Analogues Do Not Directly Affect Vascular Smooth Muscle Cell Calcification, but Induce a Procalcific to Anticalcific Paracrine Switch in Co-Cultured Human Macrophages (2008) (0)
Expression of cytochromes P450b and P450e mRNA in developing rats (1985) (0)
Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and OPG Regulation of Vascular Calcification: Roles of Phosphate and Osteopontin Angiogenesis and Pericytes in Initiation of Ectopic Calcification Role of Bone Morphogenetic Proteins in Vascular Calcification (2005) (0)
Contents Vol. 49, 2012 (2012) (0)
Treating heterotopic ossification with shockwaves. (2009) (0)
Abstract 313: Phosphorylation of Runx2 and Osteochondrogenic Differentiation of Vascular Smooth Muscle Cells (2013) (0)
Mice Lacking the Sodium-Dependent Phosphate Import Protein, Pit-1, Have a Severe Defect in Terminal Erythroid Differentiation (2011) (0)
Cross-Linking of an Esophagus Acellular Matrix Tissue-Scaffold (2005) (0)
Using Cloning and Transfection to Develop Traceable Pit 1 and Pit 2 Proteins (2011) (0)
Generation of Stable Myocardin Knockdown Smooth Muscle Cell Lines Using RNA Interference (2008) (0)
Aortic Smooth Muscle Cell Calcification and Colocalizes to Calcified Regions in Human Atherosclerotic Lesions (2004) (0)
Murine Terminal Erythroid Differentiation and Early B Development Require the Sodium-Dependent Phosphate Import Protein, PiT1. (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Cecilia M. Giachelli?

Cecilia M. Giachelli is affiliated with the following schools: